Skip to main navigation Skip to search Skip to main content

Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer

  • Donal J. Brennan
  • , Elton Rexhepaj
  • , Sallyann L. O'Brien
  • , Elaine McSherry
  • , Darran P. O'Connor
  • , Ailís I. Fagan
  • , Aedín C. Culhane
  • , Desmond G. Higgins
  • , Karin Jirstrom
  • , Robert C. Millikan
  • , Goran Landberg
  • , Michael J. Duffy
  • , Stephen M. Hewitt
  • , William M. Gallagher
  • University College Dublin
  • Harvard University
  • Lund University
  • University of North Carolina at Chapel Hill
  • National Institutes of Health

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Veterinary Science and Veterinary Medicine

Biochemistry, Genetics and Molecular Biology

Neuroscience